About PlenOptika
PlenOptika is a company based in Cambridge (United States) founded in 2014 by Nicholas Durr, Daryl Lim, Eduardo Lage, and Shivang Dave. PlenOptika has raised $50.38 thousand across 3 funding rounds from investors including HHS. PlenOptika offers products and services including QuickSee Free and QuickSee Free Pro. PlenOptika operates in a competitive market with competitors including machineMD, ArcScan, EyeNetra, Smart Vision Labs and BroadSpot Imaging, among others.
- Headquarter Cambridge, United States
- Founders Nicholas Durr, Daryl Lim, Eduardo Lage, Shivang Dave
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50.38 K (USD)
in 3 rounds
-
Latest Funding Round
$300.14 K (USD), Grant
Sep 30, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PlenOptika
PlenOptika offers a comprehensive portfolio of products and services, including QuickSee Free and QuickSee Free Pro.
Device for quick and accurate eye refraction measurements in various settings.
Advanced tool for refraction and corneal curvature assessment in clinical use.
People of PlenOptika
Unlock access to complete
Unlock access to complete
Funding Insights of PlenOptika
PlenOptika has successfully raised a total of $50.38K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $300.14 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PlenOptika
PlenOptika has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for PlenOptika
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PlenOptika
Investment portfolio details for PlenOptika
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PlenOptika
Detailed financials for PlenOptika
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Plenoptika Comparisons
Peer comparison for PlenOptika
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PlenOptika
PlenOptika operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as machineMD, ArcScan, EyeNetra, Smart Vision Labs and BroadSpot Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic device for brain diseases is developed by machineMD.
|
|
| Locked | Locked | Locked |
Ultrasound device for micron-resolution anterior chamber imaging is provided.
|
|
| Locked | Locked | Locked |
Refractive errors are measured using smartphone camera attachments.
|
|
| Locked | Locked | Locked |
Refractive errors are tested via smartphone attachment by healthcare professionals.
|
|
| Locked | Locked | Locked |
Ophthalmological imaging devices for anterior as well as posterior regions
|
Detailed competitors of PlenOptika
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Plenoptika
Complete news archive for PlenOptika
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PlenOptika
PlenOptika was founded in 2014 and raised its 1st funding round 1 year after it was founded.
PlenOptika is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Shivang Dave is the current CEO of PlenOptika. They have also founded this company.
PlenOptika is a funded company, having raised a total of $50.38K across 3 funding rounds to date.
PlenOptika is a developer of medical devices for measuring refractive errors. The objective of the device is based on dynamic aberrometry and smart Rx algorithms. It helps to precisely determine low-order refractive errors. The device is binocular with an open view to help reduce instrument induced myopia.
PlenOptika's top competitors include machineMD, EyeNetra and Smart Vision Labs.
PlenOptika offers QuickSee Free and QuickSee Free Pro.
PlenOptika has 1 investor. Key investors include HHS.